NVAX Novavax, Inc. Stock Quote

NVAX [NASD]

Index	-	P/E	-	EPS (ttm)	-14.82	Insider Own	0.30%	Shs Outstand	75.61M	Perf Week	-21.57%
Market Cap	6.23B	Forward P/E	2.90	EPS next Y	26.58	Insider Trans	-56.69%	Shs Float	75.21M	Perf Month	-56.44%
Income	-1075.00M	PEG	-	EPS next Q	-0.40	Inst Own	50.30%	Short Float	11.87%	Perf Quarter	-42.96%
Sales	1.20B	P/S	5.18	EPS this Y	-32.00%	Inst Trans	0.03%	Short Ratio	1.46	Perf Half Y	-56.87%
Book/sh	6.17	P/B	12.51	EPS next Y	315.90%	ROA	-45.20%	Target Price	250.00	Perf Year	-39.28%
Cash/sh	24.00	P/C	3.22	EPS next 5Y	0.00%	ROE	-149.70%	52W Range	66.38 - 331.68	Perf YTD	-46.03%
Dividend	-	P/FCF	13.74	EPS past 5Y	9.50%	ROI	-38.00%	52W High	-76.72%	Beta	1.38
Dividend %	-	Quick Ratio	1.20	Sales past 5Y	67.30%	Gross Margin	-	52W Low	16.32%	ATR	14.44
Employees	791	Current Ratio	1.20	Sales Q/Q	13.90%	Oper. Margin	-86.80%	RSI (14)	23.07	Volatility	13.75% 11.01%
Optionable	Yes	Debt/Eq	0.93	EPS Q/Q	-34.60%	Profit Margin	-89.30%	Rel Volume	1.23	Prev Close	79.47
Shortable	Yes	LT Debt/Eq	0.70	Earnings	Nov 04 AMC	Payout	-	Avg Volume	6.11M	Price	77.21
Recom	2.30	SMA20	-37.76%	SMA50	-51.79%	SMA200	-58.59%	Volume	7,483,488	Change	-2.84%

Jan-21-22

Initiated

Cowen

Outperform

$150

May-12-21

Downgrade

JP Morgan

Overweight → Neutral

$285 → $161

Dec-14-20

Initiated

Jefferies

Buy

$200

Aug-06-20

Reiterated

H.C. Wainwright

Buy

$132 → $290

Aug-05-20

Upgrade

JP Morgan

Neutral → Overweight

$275

Aug-05-20

Downgrade

Ladenburg Thalmann

Neutral → Sell

$105

Jul-16-20

Reiterated

H.C. Wainwright

Buy

$101 → $132

Jul-08-20

Downgrade

Ladenburg Thalmann

Buy → Neutral

$50 → $105

Jun-29-20

Reiterated

H.C. Wainwright

Buy

$50 → $101

Jun-29-20

Reiterated

B. Riley FBR

Buy

$74 → $106

Jun-05-20

Upgrade

JP Morgan

Underweight → Neutral

$46

May-28-20

Reiterated

B. Riley FBR

Buy

$53 → $61

May-12-20

Reiterated

H.C. Wainwright

Buy

$33 → $50

Apr-30-20

Reiterated

H.C. Wainwright

Buy

$24 → $33

Nov-27-19

Resumed

B. Riley FBR

Buy

$12

Aug-14-19

Reiterated

H.C. Wainwright

Buy

$10 → $17

Feb-28-19

Downgrade

Piper Jaffray

Overweight → Underweight

$4.50 → $0.25

Dec-18-18

Initiated

Ladenburg Thalmann

Buy

Dec-11-18

Initiated

Oppenheimer

Outperform

Nov-26-18

Upgrade

Piper Jaffray

Neutral → Overweight

Jan-25-22 04:43PM	COVID-19 deaths top 2,100 a day amid Omicron wave Yahoo Finance Video
08:05AM	Down 57% in 1 Month, Is Novavax a Bargain Buy? Motley Fool
05:06AM	3 Top Stocks That Can Make You Richer in January (and Beyond) Motley Fool
04:31AM	Germany to receive 3.8 mln doses of Novavax's new COVID vaccine in Q1 Reuters
Jan-24-22 06:37PM	Why Vaccine Stocks Like Moderna and Novavax Tumbled (Again) Today Motley Fool -6.12%
02:48PM	It's been a tough year so far on Wall Street. These D.C.-area companies have suffered the biggest hits. American City Business Journals
Jan-23-22 06:00AM	1 Green Flag for Novavax in 2022, and 1 Red Flag Motley Fool
Jan-21-22 05:38PM	Golden Green, Inc. Buys Xilinx Inc, Pfizer Inc, NVIDIA Corp, Sells Moderna Inc, Novavax Inc, ... GuruFocus.com -6.32%
03:47PM	COVID-19: The definition of fully vaccinated needs to be changed, doctor says Yahoo Finance Video
01:59PM	COVID-19 natural immunity is not anywhere near as safe as vaccine-induced immunity, doctor says Yahoo Finance Video
01:47PM	3 reasons why Americans aren't getting their COVID-19 booster shots Yahoo Finance Video
11:15AM	2 Growth Stocks That Could Take Off in February Motley Fool
09:38AM	Edge Wealth Management LLC Buys SPDR Biotech ETF, Salesforce. ... GuruFocus.com
09:38AM	Telos Capital Management, Inc. Buys Illumina Inc, United Parcel Service Inc, Newell Brands Inc, ... GuruFocus.com
Jan-20-22 05:35PM	Why Novavax Stock Tumbled on Thursday Motley Fool
05:14PM	Novavax Stock is in a Tough Spot, but its Fortunes Could Improve InvestorPlace
04:59PM	Coronavirus pandemic wont end magically or on its own, doctor says Yahoo Finance Video
04:35PM	Why BioNTech, Moderna, Novavax, and Ocugen Stocks Are Plunging This Week Motley Fool
03:43PM	Florida health official urging vaccinations puts DeSantis in an awkward situation, doctor says Yahoo Finance Video
12:33PM	Is Novavax Stock A Buy Or Sell As It Approaches A Potential U.S. Filing? Investor's Business Daily
Jan-19-22 06:21PM	Australia Therapeutic Goods Administration (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine PR Newswire -6.21%
04:03PM	COVID-19: 'Vaccination is the way' to keep the economy open, doctor says Yahoo Finance Video
06:30AM	Could Novavax Go Parabolic? Motley Fool
Jan-18-22 03:19PM	Omicron: Why a fourth dose of coronavirus vaccines may not be 'absolutely necessary,' doctor says Yahoo Finance Video -11.17%
07:42AM	Here's Some Good News for Novavax That Investors Are Overlooking Motley Fool
05:06AM	10 Top Stocks That Can Make You Richer in 2022 Motley Fool
Jan-17-22 09:30AM	2 Best COVID-19 Growth Stocks to Own in 2022 Motley Fool
Jan-16-22 07:01AM	What Will It Take for Novavax Stock to Rebound? Motley Fool
Jan-14-22 05:38PM	Edge Wealth Management LLC Buys SPDR Biotech ETF, Salesforce. ... GuruFocus.com
03:35PM	Novavax Still Has Not Received an FDA EUA as the Market Waits InvestorPlace
01:39PM	Moderna, Novavax, and Other Vaccine Stocks Get Whacked by Supreme Courts Vaccine Decision Barrons.com
11:02AM	NVAX Stock Alert: Why Is Novavax Plunging Today? InvestorPlace
08:16AM	Why Novavax Stock Is Tumbling Today Motley Fool
06:00AM	Here Are a Couple Billion Reasons to Hold Novavax Stock InvestorPlace
03:30AM	Vaccine-Makers Hit as Supreme Court Blocks Vaccine-or-Test Mandate Investing.com
Jan-13-22 02:19PM	NVAX Stock: One Big Reason Novavax Is Stumbling Today InvestorPlace -13.67%
01:52PM	Novavax Stock Bulls Face an Uphill Challenge InvestorPlace
06:30AM	Novavax Stock: Buy, Sell, or Hold in 2022? Motley Fool
Jan-12-22 05:45PM	Novavax (NVAX) Stock Sinks As Market Gains: What You Should Know Zacks
03:35PM	Novavax Stock Still Has A Solid Chance InvestorPlace
02:56PM	Novavax CEO: 'We're going to make a significant impact on this COVID pandemic' Yahoo Finance
11:10AM	BioMarin CEO: There are biotech companies 'that probably should not be on the market today Yahoo Finance Video
10:40AM	Novavax's COVID-19 Vaccine Gets OK In South Korea Benzinga
08:28AM	Michele Kang could gain majority stake in Washington Spirit after recent deals, according to reports American City Business Journals
07:43AM	South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine PR Newswire
06:15AM	Which Vaccine Stocks Will Make You a Fortune in 2022? Motley Fool
06:10AM	Novavax' COVID-19 vaccine wins approval in South Korea MarketWatch
06:04AM	China Blocks Some U.S. Flights After Passengers Get Covid-19, S. Korea OKs Novavax Vaccine Barrons.com
06:00AM	South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine PR Newswire
03:00AM	Yahoo Finance Presents: Cigna CEO David Cordani Yahoo Finance Video
Jan-11-22 11:56PM	UPDATE 2-S.Korea authorises Novavax COVID-19 vaccine, imports Pfizer pills Reuters
03:33PM	COVID-19: U.S. reports 1.35 million daily cases, CDC mulls recommending KN95 masks Yahoo Finance Video
01:22PM	Novavax CEO: Were on track to deliver a couple billion COVID-19 vaccine doses this year Yahoo Finance Video
Jan-10-22 05:51PM	Why Novavax Stock Jumped 6.5% Higher Today Motley Fool +6.54%
03:37PM	COVID-19 and existing care are bringing hospitals to the brink: Emergency medicine physician Yahoo Finance Video
02:52PM	Omicron: 'Vaccines still prevent serious illness, hospitalization, and death' Yahoo Finance Video
08:39AM	Novavax and Serum Institute of India File for Emergency Use Authorization of Novavax' COVID-19 Vaccine in South Africa PR Newswire
Jan-07-22 04:45PM	3 COVID Stocks That Will Make Billions in 2022 Motley Fool
04:26PM	How Nomi Health Fills in Gaps in the Health Care Industry Yahoo Finance Video
01:55PM	Novavax Remains a Worthwhile Vaccine Play InvestorPlace
01:37PM	Omicron: U.S. Supreme Court hears oral arguments about vaccine mandate amid latest surge Yahoo Finance Video
01:25PM	Moderna CEO: Another booster likely needed in the fall of 2022 Yahoo Finance Video
11:25AM	Africa's struggle to get COVID vaccine doses: 'We feel forgotten' Yahoo Finance
05:53AM	Why Novavax Stock Is Sinking This Week Motley Fool
Jan-06-22 04:31PM	COVID-19: 'There's no significant data saying there's a huge amount of transmission in school,' says doctor Yahoo Finance Video
Jan-05-22 06:05PM	Novavax Stock Could Hit $315, Says Analyst TipRanks -11.59%
04:22PM	COVID-19: Testing at the first time you have symptoms, thats really the most important time to test, says Dr. Payal Patel Yahoo Finance Video
06:00AM	Will Novavax Stock Hit $300 in 2022? Motley Fool
Jan-04-22 04:35PM	COVID-19: Were seeing more kids in emergency departments, says Dr. James Simmons Yahoo Finance Video
04:02PM	Novavax to Participate in the 40th Annual J.P. Morgan Healthcare Conference PR Newswire
11:59AM	Why Pfizer, Novavax, and Ocugen Stocks Are Sinking Today Motley Fool
11:56AM	Omicron: Theres been a lack of concern for younger children with COVID-19, doctor says Yahoo Finance Video
06:26AM	3 Biotech Stocks With Major Catalysts in January Motley Fool
06:08AM	Better Buy: Novavax vs. Moderna Motley Fool
05:58AM	Is It Time to Throw in the Towel on Novavax? Motley Fool
Jan-03-22 04:52PM	Doctor on CDC adding testing to isolation guidelines: I've agreed virtually 100% with the CDC... this is one I would push back on Yahoo Finance Video
11:42AM	Following pushback, Fauci says the CDC may require a negative COVID-19 test to end isolation MarketWatch
11:39AM	Omicron is particularly dangerous for the unvaccinated, doctor says Yahoo Finance Video
10:49AM	Company News for Jan 3, 2022 Zacks
10:24AM	Novavax (NVAX) Further Delays FDA Filing for COVID-19 Vaccine Zacks
08:22AM	Novavax submits Covid vaccine data package to FDA, its last step before emergency use application American City Business Journals
05:19AM	Novavax Slips as Covid Shot Urgent Use Filing to Take Another Month Investing.com
05:06AM	22 Stocks That Could Double Your Money in 2022 Motley Fool
Jan-01-22 06:45AM	2 Best Stocks to Invest $5,000 in Right Now Motley Fool
Dec-31-21 07:37PM	Upcoming Deadline Reminder: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm NewMediaWire -7.60%
02:50PM	UPCOMING DEADLINE ALERT: The Schall Law Firm Encourages Investors in Novavax, Inc. with Losses of $100,000 to Contact the Firm PR Newswire
01:47PM	Omicron: Doctor explains how hospitalizations are still a problem despite apparent lessened severity Yahoo Finance Video
01:04PM	NVAX Stock Alert: What Is Going on With Novavax Today? InvestorPlace
12:38PM	UPDATE 2-Novavax to submit COVID-19 vaccine EUA request to U.S. FDA next month Reuters
12:15PM	Novavax Submits Final Data Packages to U.S. FDA as Prerequisite to Emergency Use Authorization Application Request for COVID-19 Vaccine PR Newswire
08:52AM	Do Options Traders Know Something About Novavax (NVAX) Stock We Don't? Zacks
08:45AM	SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Novavax, Inc. with Losses of $100,000 to Contact the Firm ACCESSWIRE
08:27AM	Ocugen (OCGN) Up on Bharat Biotech's Data in Pediatric Group Zacks
05:06AM	It's Not Too Late to Add These 5 No-Brainer Stocks to Your IRA in 2021 Motley Fool
Dec-30-21 10:12PM	FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Novavax, Inc. - NVAX PR Newswire
03:40PM	NOVAVAX, INC. (NASDAQ:NVAX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Novavax, Inc. ACCESSWIRE
02:54PM	Investor Action Reminder: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm NewMediaWire
01:00PM	NVAX INVESTOR ALERT: Thornton Law Firm Reminds Novavax, Inc. Investors of Securities Class Action ACCESSWIRE
11:35AM	The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Novavax, Inc. (NVAX) Investors PR Newswire
11:00AM	NVAX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Novavax, Inc. Shareholders of Class Action and Lead Deadline: January 11, 2022 ACCESSWIRE

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. In addition, the company develops vaccine candidates for the protection against middle east respiratory syndrome, as well as that is in preclinical work associated with severe acute respiratory syndrome; and ebola virus glycoprotein vaccine candidate, as well as COVID-19 vaccine for variant strain. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Herrmann John A III	EVP, Chief Legal Officer	Jan 03	Option Exercise	19.08	5,000	95,400	8,845	Jan 05 05:22 PM
Herrmann John A III	EVP, Chief Legal Officer	Jan 03	Sale	140.91	5,000	704,534	3,845	Jan 05 05:22 PM
YOUNG JAMES F	Director	Dec 31	Option Exercise	25.60	3,750	96,000	78,840	Jan 04 05:04 PM
YOUNG JAMES F	Director	Dec 31	Sale	144.16	3,750	540,601	75,090	Jan 04 05:04 PM
Herrmann John A III	EVP, Chief Legal Officer	Dec 20	Option Exercise	19.08	5,000	95,400	8,845	Dec 22 05:03 PM
Herrmann John A III	EVP, Chief Legal Officer	Dec 20	Sale	230.00	5,000	1,150,000	3,845	Dec 22 05:03 PM
Glenn Gregory M	President, R&D	Dec 15	Option Exercise	34.82	1,686	58,714	7,349	Dec 16 05:15 PM
Glenn Gregory M	President, R&D	Dec 15	Sale	174.13	1,686	293,584	5,663	Dec 16 05:15 PM
DOUGLAS RICHARD	Director	Dec 13	Option Exercise	25.60	1,500	38,400	33,450	Dec 15 05:22 PM
Glenn Gregory M	President, R&D	Dec 07	Option Exercise	19.08	8,250	157,410	12,311	Dec 09 05:20 PM
Glenn Gregory M	President, R&D	Dec 07	Sale	170.14	8,250	1,403,631	4,061	Dec 09 05:20 PM
Herrmann John A III	EVP, Chief Legal Officer	Dec 01	Option Exercise	19.08	5,000	95,400	7,760	Dec 03 06:30 PM
Herrmann John A III	EVP, Chief Legal Officer	Dec 01	Sale	196.19	5,000	980,944	2,760	Dec 03 06:30 PM
Glenn Gregory M	President, R&D	Nov 30	Option Exercise	19.08	8,250	157,410	13,003	Dec 02 04:13 PM
Glenn Gregory M	President, R&D	Nov 30	Sale	203.20	8,942	1,817,000	4,061	Dec 02 04:13 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 29	Option Exercise	19.08	5,000	95,400	7,760	Dec 01 05:02 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 29	Sale	228.72	5,000	1,143,600	2,760	Dec 01 05:02 PM
Glenn Gregory M	President, R&D	Nov 26	Option Exercise	5.95	3,460	20,587	6,144	Nov 30 05:06 PM
Glenn Gregory M	President, R&D	Nov 26	Sale	218.07	2,083	454,247	4,061	Nov 30 05:06 PM
Glenn Gregory M	President, R&D	Nov 23	Option Exercise	19.08	8,250	157,410	12,311	Nov 24 05:21 PM
Glenn Gregory M	President, R&D	Nov 23	Sale	199.50	8,250	1,645,914	4,061	Nov 24 05:21 PM
Glenn Gregory M	President, R&D	Nov 16	Option Exercise	19.08	8,250	157,410	12,311	Nov 17 05:25 PM
Glenn Gregory M	President, R&D	Nov 16	Sale	169.48	8,250	1,398,180	4,061	Nov 17 05:25 PM
Glenn Gregory M	President, R&D	Nov 15	Option Exercise	37.90	1,183	44,832	5,244	Nov 17 05:25 PM
Glenn Gregory M	President, R&D	Nov 15	Sale	172.02	1,183	203,496	4,061	Nov 17 05:25 PM
Glenn Gregory M	President, R&D	Nov 09	Option Exercise	19.08	8,250	157,410	12,311	Nov 12 05:02 PM
Glenn Gregory M	President, R&D	Nov 09	Sale	167.53	8,250	1,382,160	4,061	Nov 12 05:02 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 03	Option Exercise	19.08	5,000	95,400	7,760	Nov 05 05:02 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 03	Sale	200.00	5,000	1,000,000	2,760	Nov 05 05:02 PM
Glenn Gregory M	President, R&D	Nov 02	Option Exercise	19.08	8,250	157,410	12,311	Nov 04 05:22 PM
Glenn Gregory M	President, R&D	Nov 02	Sale	183.82	8,250	1,516,552	4,061	Nov 04 05:22 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 01	Option Exercise	19.08	5,000	95,400	7,760	Nov 03 04:49 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 01	Sale	163.08	5,000	815,422	2,760	Nov 03 04:49 PM
Glenn Gregory M	President, R&D	Oct 29	Sale	148.34	680	100,871	4,061	Nov 02 07:02 PM
Glenn Gregory M	President, R&D	Oct 26	Option Exercise	15.20	11,712	178,009	14,395	Oct 28 05:09 PM
Glenn Gregory M	President, R&D	Oct 26	Sale	132.73	10,334	1,371,667	4,061	Oct 28 05:09 PM
Glenn Gregory M	President, R&D	Oct 19	Option Exercise	19.08	8,250	157,410	12,311	Oct 21 05:08 PM
Glenn Gregory M	President, R&D	Oct 19	Sale	165.14	8,250	1,362,427	4,061	Oct 21 05:08 PM
Glenn Gregory M	President, R&D	Oct 15	Option Exercise	37.90	1,183	44,832	5,244	Oct 19 05:04 PM
Glenn Gregory M	President, R&D	Oct 15	Sale	170.00	1,183	201,110	4,061	Oct 19 05:04 PM
Glenn Gregory M	President, R&D	Oct 12	Option Exercise	19.08	8,250	157,410	12,311	Oct 14 05:16 PM
Glenn Gregory M	President, R&D	Oct 12	Sale	163.18	8,250	1,346,218	4,061	Oct 14 05:16 PM
Glenn Gregory M	President, R&D	Oct 05	Option Exercise	19.08	8,250	157,410	12,311	Oct 07 05:18 PM
Glenn Gregory M	President, R&D	Oct 05	Sale	174.41	8,250	1,438,895	4,061	Oct 07 05:18 PM
Erck Stanley C	President and CEO	Oct 04	Option Exercise	27.45	42,829	1,175,583	66,708	Oct 05 05:05 PM
Erck Stanley C	President and CEO	Oct 04	Sale	176.15	42,829	7,544,195	23,879	Oct 05 05:05 PM
Herrmann John A III	EVP, Chief Legal Officer	Oct 01	Option Exercise	19.08	5,000	95,400	7,760	Oct 05 05:02 PM
Erck Stanley C	President and CEO	Oct 01	Option Exercise	27.17	49,000	1,331,400	72,879	Oct 05 05:04 PM
Erck Stanley C	President and CEO	Oct 01	Sale	175.10	49,000	8,580,064	23,879	Oct 05 05:04 PM
Herrmann John A III	EVP, Chief Legal Officer	Oct 01	Sale	174.89	5,000	874,452	2,760	Oct 05 05:02 PM
Glenn Gregory M	President, R&D	Sep 30	Sale	207.25	693	143,622	4,061	Oct 01 05:58 PM
Trizzino John	EVP, CCO and CBO	Sep 28	Option Exercise	19.08	7,501	143,119	10,047	Sep 29 05:06 PM
Trizzino John	EVP, CCO and CBO	Sep 28	Sale	209.92	7,501	1,574,637	2,546	Sep 29 05:06 PM
Trizzino John	EVP, CCO and CBO	Sep 27	Option Exercise	19.08	7,501	143,119	10,047	Sep 29 05:04 PM
Glenn Gregory M	President, R&D	Sep 27	Option Exercise	5.95	3,460	20,587	6,144	Sep 29 05:08 PM
Glenn Gregory M	President, R&D	Sep 27	Sale	234.43	2,083	488,315	4,061	Sep 29 05:08 PM
Trizzino John	EVP, CCO and CBO	Sep 27	Sale	234.61	7,501	1,759,833	2,546	Sep 29 05:04 PM
MOTT DAVID M	Director	Sep 23	Sale	252.90	24,961	6,312,616	40,000	Sep 24 05:10 PM
Trizzino John	EVP, CCO and CBO	Sep 21	Option Exercise	19.08	7,500	143,100	8,218	Sep 22 05:05 PM
Trizzino John	EVP, CCO and CBO	Sep 21	Sale	227.37	7,500	1,705,265	718	Sep 22 05:05 PM
Trizzino John	EVP, CCO and CBO	Sep 20	Option Exercise	19.08	7,500	143,100	8,218	Sep 22 05:05 PM
Trizzino John	EVP, CCO and CBO	Sep 20	Sale	227.57	7,500	1,706,748	718	Sep 22 05:05 PM
Glenn Gregory M	President, R&D	Sep 15	Option Exercise	37.90	1,183	44,832	5,244	Sep 17 05:08 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 15	Option Exercise	19.08	5,000	95,400	5,706	Sep 17 05:11 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 15	Sale	229.44	5,000	1,147,193	706	Sep 17 05:11 PM
Glenn Gregory M	President, R&D	Sep 15	Sale	229.34	1,183	271,304	4,061	Sep 17 05:08 PM
Trizzino John	EVP, CCO and CBO	Sep 14	Option Exercise	19.08	7,499	143,081	8,217	Sep 15 05:03 PM
Trizzino John	EVP, CCO and CBO	Sep 14	Sale	236.61	7,499	1,774,360	718	Sep 15 05:03 PM
Trizzino John	EVP, CCO and CBO	Sep 13	Option Exercise	19.08	7,499	143,081	8,217	Sep 15 05:03 PM
Trizzino John	EVP, CCO and CBO	Sep 13	Sale	235.29	7,499	1,764,433	718	Sep 15 05:03 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 01	Option Exercise	19.08	5,000	95,400	5,706	Sep 03 05:10 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 01	Sale	247.97	5,000	1,239,867	706	Sep 03 05:10 PM
Glenn Gregory M	President, R&D	Aug 31	Sale	239.87	1,386	332,463	4,061	Sep 01 05:23 PM
Glenn Gregory M	President, R&D	Aug 26	Option Exercise	5.95	6,921	41,180	8,228	Aug 30 06:16 PM
Glenn Gregory M	President, R&D	Aug 26	Sale	233.92	4,167	974,740	4,061	Aug 30 06:16 PM
Glenn Gregory M	President, R&D	Aug 16	Option Exercise	40.64	1,866	75,826	5,927	Aug 18 05:26 PM
Glenn Gregory M	President, R&D	Aug 16	Sale	233.52	1,866	435,750	4,061	Aug 18 05:26 PM
Herrmann John A III	EVP, Chief Legal Officer	Jul 26	Option Exercise	14.83	2,896	42,960	3,602	Jul 28 05:00 PM
Herrmann John A III	EVP, Chief Legal Officer	Jul 26	Sale	197.74	2,896	572,648	706	Jul 28 05:00 PM
Glenn Gregory M	President, R&D	Jul 20	Sale	215.43	2,409	518,982	2,811	Jul 22 05:20 PM
Glenn Gregory M	President, R&D	Jul 15	Option Exercise	13.08	10,477	137,006	8,465	Jul 19 07:52 PM
Glenn Gregory M	President, R&D	Jul 15	Sale	179.45	5,654	1,014,597	2,811	Jul 19 07:52 PM
Erck Stanley C	President and CEO	Jul 02	Option Exercise	80.66	52,559	4,239,511	73,054	Jul 06 05:03 PM
Erck Stanley C	President and CEO	Jul 02	Sale	215.89	52,559	11,347,066	20,495	Jul 06 05:03 PM
Erck Stanley C	President and CEO	Jul 01	Option Exercise	61.59	52,620	3,240,965	73,115	Jul 06 05:03 PM
Erck Stanley C	President and CEO	Jul 01	Sale	212.88	52,620	11,201,513	20,495	Jul 06 05:03 PM
Glenn Gregory M	President, R&D	Jun 17	Sale	183.28	2,411	441,887	2,811	Jun 17 06:17 PM
Glenn Gregory M	President, R&D	Jun 15	Option Exercise	13.16	10,535	138,685	8,527	Jun 17 06:17 PM
Glenn Gregory M	President, R&D	Jun 15	Sale	191.42	5,716	1,094,130	2,811	Jun 17 06:17 PM
EVANS GARY C	Director	Jun 01	Sale	146.50	625	91,562	0	Jun 03 05:34 PM
Herrmann John A III	EVP, Chief Legal Officer	May 28	Option Exercise	14.83	2,895	42,932	3,170	Jun 02 04:59 PM
Herrmann John A III	EVP, Chief Legal Officer	May 28	Sale	149.14	2,895	431,748	275	Jun 02 04:59 PM
King Rachel K.	Director	May 19	Buy	139.64	700	97,748	2,800	May 21 05:06 PM
Glenn Gregory M	President, R&D	May 19	Sale	142.17	2,385	339,066	2,811	May 19 05:26 PM
Glenn Gregory M	President, R&D	May 17	Option Exercise	13.16	10,531	138,577	8,523	May 19 05:26 PM
Glenn Gregory M	President, R&D	May 17	Sale	133.98	5,712	765,267	2,811	May 19 05:26 PM
Trizzino John	EVP, CCO, CBO & Interim CFO	May 07	Sale	176.63	190	33,559	287	May 07 05:10 PM
Trizzino John	EVP, CCO, CBO & Interim CFO	May 05	Option Exercise	14.73	3,406	50,160	3,309	May 07 05:10 PM
Trizzino John	EVP, CCO, CBO & Interim CFO	May 05	Sale	185.46	3,022	560,471	287	May 07 05:10 PM
Herrmann John A III	EVP, Chief Legal Officer	Apr 30	Option Exercise	14.82	2,895	42,892	3,170	May 04 06:03 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience